IP Library Granted Patent US 8,652,823
Granted Patent B2
US 8,652,823 · App. 12/625,593 · Granted Feb 18, 2014

Strain for butanol production with increased membrane unsaturated trans fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,823
App. No.
12/625,593
Granted
Feb 18, 2014
Kind
B2
Abstract

Bacteria that are not natural butanol producers were found to have increased tolerance to butanol when the membrane content of unsaturated trans fatty acids was increased. Feeding cells with unsaturated trans fatty acids increased their concentration in the membrane, which may also be accomplished by expressing a fatty acid cistrans isomerase.

Claims (32)

1. An isobutanol tolerant Lactobacillus bacterial cell comprising:

(a) an engineered isobutanol biosynthetic pathway, wherein the Lactobacillus bacterial cell comprises heterologous genes encoding an acetolactate synthase, an acetohydroxy acid isomeroreductase, an acetohydroxy acid dehydratase or dihydroxyacid dehydratase, a branched-chain keto acid decarboxylase, and a branched-chain alcohol dehydrogenase that perform the following substrate to product conversions:

(i) pyruvate to acetolactate catalyzed by the acetolactate synthase,

(ii) acetolactate to 2,3-dihydroxyisovalerate catalyzed by the acetohydroxy acid isomeroreductase,

(iii) 2,3-dihydroxyisovalerate to α-ketoisovalerate catalyzed by the acetohydroxy acid dehydratase or dihydroxyacid dehydratase,

(iv) α-ketoisovalerate to isobutyraldehyde catalyzed by the branched-chain keto acid decarboxylase, and

(v) isobutyraldehyde to isobutanol catalyzed by the branched-chain alcohol dehydrogenase; and

(b) at least one gene encoding a heterologous fatty acid cistrans isomerase, wherein the isobutanol tolerant Lactobacillus bacterial cell has increased concentration of membrane unsaturated trans fatty acids as compared with that of the corresponding Lactobacillus bacterial cell that lacks the at least one gene encoding a heterologous fatty acid cistrans isomerase.

2. The isobutanol tolerant Lactobacillus bacterial cell of claim 1 , wherein the concentration of at least one unsaturated trans fatty acid selected from the group consisting of elaidic acid, vaccenic acid, and C16:1 trans fatty acid is increased as compared with that of the corresponding Lactobacillus bacterial cell that lacks the at least one gene encoding a heterologous fatty acid cistrans isomerase.

3. The isobutanol tolerant Lactobacillus bacterial cell of claim 1 , wherein said cell produces isobutanol and the growth yield of the cell is at least 1.6 to about 3.5-fold higher in a culture medium comprising 2.5% isobutanol than the corresponding Lactobacillus bacterial cell that lacks the at least one gene encoding a heterologous fatty acid cistrans isomerase.

4. The isobutanol tolerant Lactobacillus bacterial cell of claim 1 , wherein the concentration of at least one membrane unsaturated trans fatty acid is about 44-fold higher than that of the corresponding Lactobacillus bacterial cell that lacks the at least one gene encoding a heterologous fatty acid cistrans isomerase.

5. A method for the production of isobutanol comprising:

(I) providing an isobutanol tolerant Lactobacillus bacterial cell that comprises:

(a) an engineered isobutanol biosynthetic pathway, wherein the Lactobacillus bacterial cell comprises heterologous genes encoding an acetolactate synthase, an acetohydroxy acid isomeroreductase, an acetohydroxy acid dehydratase or dihydroxyacid dehydratase, a branched-chain keto acid decarboxylase, and a branched-chain alcohol dehydrogenase that perform the following substrate to product conversions:

(i) pyruvate to acetolactate catalyzed by the acetolactate synthase,

(ii) acetolactate to 2,3-dihydroxyisovalerate catalyzed by the acetohydroxy acid isomeroreductase,

(iii) 2,3-dihydroxyisovalerate to α-ketoisovalerate catalyzed by the acetohydroxy acid dehydratase or dihydroxyacid dehydratase,

(iv) α-ketoisovalerate to isobutyraldehyde catalyzed by the branched-chain keto acid decarboxylase, and

(v) isobutyraldehyde to isobutanol catalyzed by the branched-chain alcohol dehydrogenase; and

(b) at least one gene encoding a heterologous fatty acid cistrans isomerase, wherein the isobutanol tolerant Lactobacillus bacterial cell has increased concentration of membrane unsaturated trans fatty acids as compared with that of the corresponding Lactobacillus bacterial cell that lacks the at least one gene encoding a heterologous fatty acid cistrans isomerase;

(II) feeding the Lactobacillus bacterial cell of step (I) at least one trans fatty acid under conditions wherein the concentration of unsaturated trans fatty acids in the membrane of the cell are increased; and

(III) growing the Lactobacillus bacterial cell of step (II) under conditions wherein isobutanol is produced.

6. A method for the production of isobutanol comprising:

(I) providing an isobutanol tolerant Lactobacillus bacterial cell that comprises:

(a) an engineered isobutanol biosynthetic pathway, wherein the Lactobacillus bacterial cell comprises heterologous genes encoding an acetolactate synthase, an acetohydroxy acid isomeroreductase, an acetohydroxy acid dehydratase or dihydroxyacid dehydratase, a branched-chain keto acid decarboxylase, and a branched-chain alcohol dehydrogenase that perform the following substrate to product conversions:

(i) pyruvate to acetolactate catalyzed by the acetolactate synthase,

(ii) acetolactate to 2,3-dihydroxyisovalerate catalyzed by the acetohydroxy acid isomeroreductase,

(iii) 2,3-dihydroxyisovalerate to α-ketoisovalerate catalyzed by the acetohydroxy acid dehydratase or dihydroxyacid dehydratase,

(iv) α-ketoisovalerate to isobutyraldehyde catalyzed by the branched-chain keto acid decarboxylase, and

(v) isobutyraldehyde to isobutanol catalyzed by the branched-chain alcohol dehydrogenase; and

(b) at least one gene encoding a heterologous fatty acid cistrans isomerase, wherein the isobutanol tolerant Lactobacillus bacterial cell has increased concentration of membrane unsaturated trans fatty acids as compared with that of the corresponding Lactobacillus bacterial cell that lacks the at least one gene encoding a heterologous fatty acid cistrans isomerase; and

(II) growing the Lactobacillus bacterial cell of step (I) under conditions wherein isobutanol is produced.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2010
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 024216/0243 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2010
From: FLINT, DENNIS; VAN DYK, TINA K.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 024002/0799 →